Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Diagnostic Accuracy Study Comparing CT and MRI (VI-RADS) for Local Staging of Newly Diagnosed Bladder Cancer

NCT07602010 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT07602010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07602010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Diagnostic Accuracy Study Comparing CT and MRI (VI-RADS) for Local Staging of Newly Diagnosed Bladder Cancer
Lead sponsor
Oslo University Hospital
Phase
Observational
Overall status
Recruiting
Start date
April 22, 2026
Completion date
October 31, 2028
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, muscle invasive bladder cancer (mibc), non muscle invasive bladder cancer, urothelial carcinoma (uc)